Search for 'Parkinson’s disease'

Search in texts for 'Parkinson’s disease' - Neurosonology.net'

Also try: Parkinson's disease, parkinson disease,

69 results of 22 texts with exact phrase : 'Parkinson’s disease'.

1. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 1, 2005, No. 2 , , ,

10th International Congress of Parkinson’s Disease and Movement Disorders
10th International Congress of Parkinson’s Disease and Movement Disorders
read the entire text >>

2. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 2, 2006, No. 1 , , ,

Microelectrode recording of globus pallidus externa (Gpe) and interna (Gpi) during pallidotomy procedure for symptomatic neurosurgical treatment for patients with Parkinson’s Disease.
Microelectrode recording of globus pallidus externa (Gpe) and interna (Gpi) during pallidotomy procedure for symptomatic neurosurgical treatment for patients with Parkinson’s Disease.
read the entire text >>

3. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 2, 2006, No. 2 , , ,

Baykushev are in the field of epileptology, vascular diseases, recovery after stroke, and Parkinson’s disease.
The main neurological activities of Prof. Baykushev are in the field of epileptology, vascular diseases, recovery after stroke, and Parkinson’s disease. He was a consulting professor in many Neurological Wards of the country and also a national consultant of neurology for Southern Bulgaria. Under his leadership ten EMG laboratories have been created in different hospitals of the country. He also introduced some new EMG methods as well as the technique of somatosensory and motor evoked potentials in Bulgaria.
read the entire text >>

4. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 3, 2007, No. 1 , , ,

The interplay between behaivior and neurodegeneration in rat models of Parkinson’s disease and stroke.
Woodlee MT, Schallert T. The interplay between behaivior and neurodegeneration in rat models of Parkinson’s disease and stroke.
read the entire text >>

5. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 3, 2007, No. 2 , , ,

Repetitive transcranial magnetic stimulation worsens complex movements in Parkinson’s disease.
Boylan LS, Pullman SL, Lisanby SH, Spicknall KE, Sackeim HA. Repetitive transcranial magnetic stimulation worsens complex movements in Parkinson’s disease.
read the entire text >>

Akinesia in Parkinson’s disease. ІІ.
Pascual-Leone A, Valls-Sole J, Brasil-Neto JP, Cammarota A, Grafman J, Hallett M. Akinesia in Parkinson’s disease. ІІ. Shortening of choise reaction time and movement time with subthreshold repetitive transcranial motor cortex stimulation,
read the entire text >>

Lack of clinical improvement in patients with Parkinson’s disease after low and higt-frequency repetitive transcranial magnetic stimulation.
Tergau F, Wassermann EM, Paulus W, Ziemann U. Lack of clinical improvement in patients with Parkinson’s disease after low and higt-frequency repetitive transcranial magnetic stimulation.
read the entire text >>

17th International Congress on Parkinson’s Disease and Related Disorders
17th International Congress on Parkinson’s Disease and Related Disorders
read the entire text >>

6. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 4, 2008, No. 1 , , ,

13th International Congress of Parkinson’s Disease
13th International Congress of Parkinson’s Disease
read the entire text >>

7. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 5, 2009, No. 1 , , ,

XVIII WFN World Congress on Parkinson’s Disease and Related Disorders
XVIII WFN World Congress on Parkinson’s Disease and Related Disorders
read the entire text >>

8. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 5, 2009, No. 1 , , ,

XVIII WFN World Congress on Parkinson’s Disease and Related Disorders
XVIII WFN World Congress on Parkinson’s Disease and Related Disorders
read the entire text >>

9. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 6, 2010, No. 1 , , ,

International Congress on Mental Dysfunctions and Other Non-Motor Features in Parkinson’s Disease
International Congress on Mental Dysfunctions and Other Non-Motor Features in Parkinson’s Disease
read the entire text >>

10. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 6, 2010, No. 2 , , ,

Evaluation of the Hospital Anxiety and Depression Scale in patients with Parkinson’s disease.
Marinus J, Leentjens AFG, Visser M, Stiggelbout AM, van Hilten JJ. Evaluation of the Hospital Anxiety and Depression Scale in patients with Parkinson’s disease.
read the entire text >>

on Mental Dysfunctions and Other Non-Motor Features in Parkinson’s Disease
on Mental Dysfunctions and Other Non-Motor Features in Parkinson’s Disease
read the entire text >>

11. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 7, 2011, No. 1 , , ,

MDS 14th International Congress of Parkinson‘s Disease and Movement Disorders
MDS 14th International Congress of Parkinson‘s Disease and Movement Disorders
read the entire text >>

His monographs Shoulder-hand Syndrome, Neurovegetative Pathology of the Hand, Clinical Neurovegetology and Border Problems as well as his participations and editorship in Diseases of the Hand, Parkinson’s Disease are of renown and popularity.
He was well known among his colleagues and graduates with his vocational interests on the problems of neurovegetology and border conditions, diseases of the hand, occupational diseases of the nervous and musculoskeletal systems, parkinsonism, pain and neural therapy in medicine. His monographs Shoulder-hand Syndrome, Neurovegetative Pathology of the Hand, Clinical Neurovegetology and Border Problems as well as his participations and editorship in Diseases of the Hand, Parkinson’s Disease are of renown and popularity. He is an author of more than
read the entire text >>

He was a vice-president of the Bulgarian Parkinsonism Foundation, a member of the Scientific Council of the European Parkinson’s Disease Association, of the Scientific European Neural Therapy Council, of the European Society for Microcirculation, of the Bulgarian National Medical Academy, a regular member of the Union of Scientists in Bulgaria for many years, organizer and leader of many scientific meetings, scientific and research national and international projects.
social activities. In 1997 he founded and became the president of Atlanto-Euro-Mediterranean Academy of Medical Sciences (АЕM АМS). He was a vice-president of the Bulgarian Parkinsonism Foundation, a member of the Scientific Council of the European Parkinson’s Disease Association, of the Scientific European Neural Therapy Council, of the European Society for Microcirculation, of the Bulgarian National Medical Academy, a regular member of the Union of Scientists in Bulgaria for many years, organizer and leader of many scientific meetings, scientific and research national and international projects.
read the entire text >>

12. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 8, 2012, No. 1 , , ,

Parkinson’s disease (PD).
Parkinson’s disease (PD).
read the entire text >>

TMS is used clinically in the differentiation of idiopathic Parkinson’s disease (normal pyramidal tract) from symptomatic forms.
TMS is used clinically in the differentiation of idiopathic Parkinson’s disease (normal pyramidal tract) from symptomatic forms. CMCT in PD is in normal limits and is prolonged in patients with multisystemic atrophy [3]. The method “entryexit curve” with stimuli of equal intensity shows higher MEP amplitude at rest in patients with PD compared to healthy persons [54]. The shortened cortical “silent period” at high intensity stimulation in PD becomes more prolonged after L-dopa or surgical treatment. Some authors use this fact as an objective method for treatment effectiveness control [8, 44].
read the entire text >>

Parkinson`s disease rigidity: Magnetic motor evoked potentials in a small hand muscle.
Cantello R, Gianelli M, Bettucci D, De Angelis S, Mutani R. Parkinson`s disease rigidity: Magnetic motor evoked potentials in a small hand muscle.
read the entire text >>

Placebo-controlled study of rTMS for the treatment of Parkinson’s disease.
Lomarev MP, Kanchana S, Bara-Jimenez W, Iyer M, Wassermann EM, Hallett M. Placebo-controlled study of rTMS for the treatment of Parkinson’s disease.
read the entire text >>

Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson`s disease and drug-induced parkinsonism.
Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson`s disease and drug-induced parkinsonism.
read the entire text >>

Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson’s disease.
Valls-Solé J, Pascual-Leone A, Brasil-Neto JP, Cammarota A, McShane L, Hallett M. Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson’s disease.
read the entire text >>

pure autonomic failure, multiple system atrophy, Parkinson’s disease, Lewy body dementia.
pure autonomic failure, multiple system atrophy, Parkinson’s disease, Lewy body dementia.
read the entire text >>

Rehabilitation treatment and interdisciplinary approach may improve the condition of patients with progressive neurologic disorders such as multiple sclerosis, Parkinson’s disease, amyotrophic lateral sclerosis, muscular dystrophy and neuropathy.
Rehabilitation treatment and interdisciplinary approach may improve the condition of patients with progressive neurologic disorders such as multiple sclerosis, Parkinson’s disease, amyotrophic lateral sclerosis, muscular dystrophy and neuropathy. The choice of a wheelchair is crucial in progressive neurologic disorders [1].
read the entire text >>

It is proved that patients with Parkinson’s disease benefit from regular physical exercises focusing on balance and gait [22].
It is proved that patients with Parkinson’s disease benefit from regular physical exercises focusing on balance and gait [22]. Appropriate goals and therapies are specific for the disease stage and the needs and values of the individual patient. Preliminary evidence supports moderate aerobic and strengthening regimens in these patients. Close monitoring and avoidance of fatigue are paramount. Assistive technologies play an ever-increasing role in maintaining independence during all stages of the disease. Home modifications and adaptive equipment are frequently needed.
read the entire text >>

13. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 9, 2013, No. 1 , , ,

International Congress of Parkinson‘s Disease and Movement Disorders
International Congress of Parkinson‘s Disease and Movement Disorders
read the entire text >>

14. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 9, 2013, No. 2 , , ,

A Semi-Quantified Evaluation of Substantia Nigra Hyperechogenicity in Parkinson’s Disease and Parkinsonian Syndrome.
A Semi-Quantified Evaluation of Substantia Nigra Hyperechogenicity in Parkinson’s Disease and Parkinsonian Syndrome.
read the entire text >>

Comparison of Closed and Open Kinetic Chain Exercise in Patients with Parkinson’s Disease.
Comparison of Closed and Open Kinetic Chain Exercise in Patients with Parkinson’s Disease.
read the entire text >>

Web-based Interactive Simulation of a Clinical Case with Parkinson’s Disease.
Web-based Interactive Simulation of a Clinical Case with Parkinson’s Disease.
read the entire text >>

15. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 10, 2014, No. 2 , , ,

Normal aging process and many different neurological disorders like stroke, dementia, Alzheimer’s and Parkinson’s disease, Huntington disease, multiple sclerosis and acquired brain trauma contribute to the decline of our cognitive abilities.
phenomenon known as "learned non use". With the loss of a brain area’s function, the body part that was linked to this area is also affected and its mobility power is lost too. As the patient can not move his most affected limb, he compensates this using the other limb. Thus, after a certain period, when the damage effects aren’t present anymore and brain adaptations happen, the movements could be recovered, but the patient has already 'learned" that the limb is no longer functional [1]. Cognitive abilities like processing speed, memory and reasoning start to decline in our late twenties. Normal aging process and many different neurological disorders like stroke, dementia, Alzheimer’s and Parkinson’s disease, Huntington disease, multiple sclerosis and acquired brain trauma contribute to the decline of our cognitive abilities.
read the entire text >>

Besides the specific substantia nigra (SN) hyperechogenicity in about 90% of Parkinson’s disease (PD) patents, that was first time described in 1995 by Becker et al.
Besides the specific substantia nigra (SN) hyperechogenicity in about 90% of Parkinson’s disease (PD) patents, that was first time described in 1995 by Becker et al. [1], numerous TCS studies reported other specific ultrasound features in various other neurodegenerative diseases.
read the entire text >>

K. Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography.
K. Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography.
read the entire text >>

ger A, Lange KW, Reiners K, Becker T, Becker G.Depression in Parkinson’s disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging.
ger A, Lange KW, Reiners K, Becker T, Becker G.Depression in Parkinson’s disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging.
read the entire text >>

16. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 11, 2015, No. 2 , , ,

P16 Ultrasound Brain Parenchyma Imaging in Parkinson΄s Disease.
P16 Ultrasound Brain Parenchyma Imaging in Parkinson΄s Disease.
read the entire text >>

P33 Influence of Kinesitherapy on Functional Mobility in Patients with Parkinson’s Disease.
P33 Influence of Kinesitherapy on Functional Mobility in Patients with Parkinson’s Disease.
read the entire text >>

The severity of Parkinson’s disease was evaluated by the scales of Hoehn and Yahr and Unified Parkinson’s Disease Rating Scale (UPDRS), and the cognitive capacity – by Mini Mental State Examination Scale.
tial tremor, confirmed by SPECT (DaTscan). The severity of Parkinson’s disease was evaluated by the scales of Hoehn and Yahr and Unified Parkinson’s Disease Rating Scale (UPDRS), and the cognitive capacity – by Mini Mental State Examination Scale. The results were compared with healthy controls at the same age.
read the entire text >>

ON FUNCTIONAL MOBILITY IN PATIENTS WITH PARKINSON’S DISEASE
ON FUNCTIONAL MOBILITY IN PATIENTS WITH PARKINSON’S DISEASE
read the entire text >>

Daily activities and motor disability tested by Unified Parkinson’s Disease Rating Scale, time of position change (lying to sitting, sitting to standing) and 10 meters walking have been studied.
session of kinesitherapy. Daily activities and motor disability tested by Unified Parkinson’s Disease Rating Scale, time of position change (lying to sitting, sitting to standing) and 10 meters walking have been studied.
read the entire text >>

17. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 12, 2016, No. 2 , , ,

Parkinson’s disease.
Parkinson’s disease.
read the entire text >>

First experience with MR-guided focused ultrasound in the treatment of Parkinson’s disease.
hler R, Moser D, Kowalski M, Pourtehrani P, Jeanmonod D. First experience with MR-guided focused ultrasound in the treatment of Parkinson’s disease.
read the entire text >>

MRI guided focused ultrasound thalamotomy for moderate-to-severe tremor in Parkinson’s disease.
Schlesinger I, Eran A, Sinai A, Erikh I, Nassar M, Goldsher D, Zaaroor M. MRI guided focused ultrasound thalamotomy for moderate-to-severe tremor in Parkinson’s disease.
read the entire text >>

P3 Transcranial Brain Sonography Findings in Parkinson’s Disease: First Results from Tuzla, Bosnia and Herzegovina.
P3 Transcranial Brain Sonography Findings in Parkinson’s Disease: First Results from Tuzla, Bosnia and Herzegovina.
read the entire text >>

18. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 13, 2017, No. 1 , , ,

International Congress of Parkinson‘s Disease and Movement Disorders
International Congress of Parkinson‘s Disease and Movement Disorders
read the entire text >>

World Congress on Parkinson‘s Disease and Related Disorders
World Congress on Parkinson‘s Disease and Related Disorders
read the entire text >>

19. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 13, 2017, No. 2 , , ,

Meta-analysis of 12 studies (25) (n=1574299) evaluating the association of the adherence to a Mediterranean diet and the mortality and incidence of major cardiovascular diseases (CVD) and chronic neurodegenerative diseases showed that the greater adherence to a Mediterranean diet was associated with significant reduction in overall mortality (9%), mortality from CVD (9%), incidence of or mortality from cancer (6%), and incidence of Parkinson’s disease and Alzheimer’s disease (13%) [25].
Meta-analysis of 12 studies (25) (n=1574299) evaluating the association of the adherence to a Mediterranean diet and the mortality and incidence of major cardiovascular diseases (CVD) and chronic neurodegenerative diseases showed that the greater adherence to a Mediterranean diet was associated with significant reduction in overall mortality (9%), mortality from CVD (9%), incidence of or mortality from cancer (6%), and incidence of Parkinson’s disease and Alzheimer’s disease (13%) [25]. Mediterranean Diet and Incidence and Mortality from Coronary Heart Disease and Stroke in Women study [12] was performed in 4886 women, with no history of cardiovascular disease and diabetes (Nurses’ Health Study) and followed up. Alternate Mediterranean Diet Score (aMED), focusing on higher consumption of plant foods, including plant proteins, monounsaturated fat, fish and lower consumption of animal products and saturated fat ranged from 0 to 9, with a higher score representing closer resemblance to the
read the entire text >>

Diseases like Parkinson’s disease (1.1%) or multiple sclerosis (0.6%) cause a comparatively low burden of DALY.
reaching approximately 40% within the first 30 days after the bleeding, and a higher morbidity [61]. Only approximately 20% of ICH patients are functionally independent at 6 months [49]. A recent analysis of the Global Burden of Disease Study focusing on the neurological field confirmed the important role of so called “hemorrhagic strokes” (a term including ICH and SAH) as the cause of the highest mortality and morbidity as compared to all other diseases from the neurological spectrum [8]. Looking at DisabilityAdjusted Life-Years (DALY), hemorrhagic strokes are the number one DALY cause (35.7% of DALY caused by any neurological diseases), followed by ischemic stroke with 22.4%, migraine (12.7%), epilepsy (9.9%), dementia (6.4%). Diseases like Parkinson’s disease (1.1%) or multiple sclerosis (0.6%) cause a comparatively low burden of DALY. For better understanding a DALY can be described as the loss of one healthy year of one’s life.
read the entire text >>

20. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 14, 2018, No. 1 , , ,

On the basis of their studies, new methods for treating certain diseases such as Parkinson’s disease, phantom pain, post-stroke hemiparesis and others have been developed.
Over the past decade the physiology and pathology of the mirror neurons have intrigued more and more scientists. On the basis of their studies, new methods for treating certain diseases such as Parkinson’s disease, phantom pain, post-stroke hemiparesis and others have been developed.
read the entire text >>

Besides the specific finding of the substantia nigra (SN) hyperechogenicity in up to 90% of Parkinson’s disease (PD) patents, first time described in 1995 by Becker et al.
Besides the specific finding of the substantia nigra (SN) hyperechogenicity in up to 90% of Parkinson’s disease (PD) patents, first time described in 1995 by Becker et al. [1], a series of studies using TCS has reported another specific ultrasound feature: structural abnormality of the midbrain raphe depicted as reduced echogenicity or invisible brainstem raphe (BR) in patients with unipolar depression compared with healthy individuals [2, 3]. The same structural abnormality has also been reported when depressed patients have been compared to non-depressed patients, having a variety of neurological diseases, for example, PD [4, 5], dystonic syndromes [15] and Wilson’s disease [18] but not multiple sclerosis with or without depression [6, 7].
read the entire text >>

K. Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography.
K. Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography.
read the entire text >>

Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography.
Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M, et al. Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography.
read the entire text >>

Depression in Parkinson’s disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging.
Berg D, Supprian T, Hofmann E, Zeiler B, Jager A, Lange KW, et al. Depression in Parkinson’s disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging.
read the entire text >>

21. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 14, 2018, No. 2 , , ,

in a Patient with Parkinson’s Disease.
in a Patient with Parkinson’s Disease.
read the entire text >>

Orthostatic Hypotension in Patients with Parkinson’s Disease.
Orthostatic Hypotension in Patients with Parkinson’s Disease.
read the entire text >>

ORTHOSTATIC HYPOTENSION IN PATIENTS WITH PARKINSON’S DISEASE
ORTHOSTATIC HYPOTENSION IN PATIENTS WITH PARKINSON’S DISEASE
read the entire text >>

The self-reported questionnaire is a useful and necessary instrument for diagnosis of orthostatic hуpotension in patients with Parkinson’s disease.
The self-reported questionnaire is a useful and necessary instrument for diagnosis of orthostatic hуpotension in patients with Parkinson’s disease.
read the entire text >>

She is Principal Investigator, National Coordinator or contributor to a number of international trials in the field of stroke, multiple sclerosis, epilepsy and Parkinson’s disease.
new directions in ultrasound diagnostics of the nervous system in Bulgaria and abroad. She is Principal Investigator, National Coordinator or contributor to a number of international trials in the field of stroke, multiple sclerosis, epilepsy and Parkinson’s disease. She has been a guest lecturer in Serbia, Croatia, Finland, Mexico and Georgia and chairperson in many national and international scientific events.
read the entire text >>

22. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 15, 2019, No. 1 , , ,

The Influence of Gender on Cardiovascular Autonomic Function in Patients with Parkinson’s Disease
The Influence of Gender on Cardiovascular Autonomic Function in Patients with Parkinson’s Disease
read the entire text >>

Parkinson’s disease
Parkinson’s disease
read the entire text >>

The United Parkinson’s disease rating scale (UPRDS) and Hoen and Yahr (HY) scale were used to evaluate the severity of the disease.
In all patients, the onset and duration of the disease, the type of the treatment, the precise somatic and neurological status were recorded. During the study, the patients received their usual therapy and were in “on” phase. The United Parkinson’s disease rating scale (UPRDS) and Hoen and Yahr (HY) scale were used to evaluate the severity of the disease.
read the entire text >>

Включващи критерии са: клинична диагноза ПБ съгласно критериите на UK Parkinson’s disease Society Brain Bank [13], липса на когнитивен дефицит, оценен чрез Mini Mental State Examination (MMSE), отсъствието на данни за хронични соматични или други заболявания засягащи първично или вторично автономната нервна система, и прием единствено на антипаркинсонови медикаменти.
В проучването са включени 55 пациента с ПБ и 40 здрави лица от същата възрастова група. Включващи критерии са: клинична диагноза ПБ съгласно критериите на UK Parkinson’s disease Society Brain Bank [13], липса на когнитивен дефицит, оценен чрез Mini Mental State Examination (MMSE), отсъствието на данни за хронични соматични или други заболявания засягащи първично или вторично автономната нервна система, и прием единствено на антипаркинсонови медикаменти. Голяма част от пациентите (76%) са на levodopa терапия със средна дневна доза 522.2±379.1 mg/дн.
read the entire text >>

The application of a set of tools (selfassessment questionary and specialized functional autonomic tests) to identify the intergender differences in the different aspects of the Parkinson’s disease, motor and nonmotor, gives opportunity for more precise clinical evaluation, therapy, and prognosis of the disease.
The application of a set of tools (selfassessment questionary and specialized functional autonomic tests) to identify the intergender differences in the different aspects of the Parkinson’s disease, motor and nonmotor, gives opportunity for more precise clinical evaluation, therapy, and prognosis of the disease.
read the entire text >>

Gender and the Parkinson’s disease phenotype.
Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Gender and the Parkinson’s disease phenotype.
read the entire text >>

Early abnormalities of vascular and cardiac autonomic control in Parkinson’s disease without orthostatic hypotension.
Barbic F, Perego F, Canesi M, Gianni M, Biagiotti S, Constantino G, Pezzoli G, Porta A, Malliani a, Furlan F. Early abnormalities of vascular and cardiac autonomic control in Parkinson’s disease without orthostatic hypotension.
read the entire text >>

Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson’s disease.
Orimo S, Takahashi A, Uchihara T, Mori F, Kakita A, Wakabayashi K, Takahashi H. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson’s disease.
read the entire text >>

Parkinson’s disease in women: a call fo rimproved clinical studies and for comparativ eeffectiveness research.
Pavon JM, Whitson HE, Okun MS. Parkinson’s disease in women: a call fo rimproved clinical studies and for comparativ eeffectiveness research.
read the entire text >>

The relevance of gender in Parkinson’s disease: a review.
Picillo M, Nicoletti A, Fetoni V, Garavaglia B, Barone P, Pellecchia MT. The relevance of gender in Parkinson’s disease: a review.
read the entire text >>

Clinical determinants of health-related quality of life in Mexican patients with Parkinson’s disease.
n P. Clinical determinants of health-related quality of life in Mexican patients with Parkinson’s disease.
read the entire text >>

Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity.
Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity.
read the entire text >>

Back to Top